Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02495155 · ClinicalTrials.gov registry record · NA

Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer

A NA study of Breast Cancer and Pain, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT02495155 is a NA study of Breast Cancer and Pain that has completed, run by University of Michigan. The registered enrollment target is 45 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02495155, a NA study of Breast Cancer and Pain, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

In order to determine the acceptability of a breast cancer-specific cognitive behavioral therapy intervention, as well as to obtain preliminary data to assess efficacy in managing symptoms, the investigators will ask 45 breast cancer survivors with moderate insomnia, fatigue, and/or pain to use the investigators' internet-based intervention for 8 weeks and to complete patient-reported outcomes assessments before and after the 8 week intervention.

Interventions

  • BEHAVIORAL PROSPECT

Study Locations (1)

Michigan

  • University of Michigan Comprehensive Cancer Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2015-06
Est. Completion 2016-06
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02495155

The ClinicalTrials.gov registry entry for NCT02495155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which PROSPECT is the first listed.

NCT02495155 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02495155 about?

NCT02495155 is a clinical study titled "Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer". In order to determine the acceptability of a breast cancer-specific cognitive behavioral therapy intervention, as well as to obtain preliminary data to assess efficacy in managing symptoms, the investigators will ask 45 breast cancer survivors with moderate insomnia, fatigue, and/or pain to use the ...

What is the current status of trial NCT02495155?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-06. Estimated completion is 2016-06.

What conditions does trial NCT02495155 study?

This clinical trial studies the following conditions: Breast Cancer, Pain, Insomnia, Fatigue.

What interventions are being tested in trial NCT02495155?

The interventions under investigation include: PROSPECT (BEHAVIORAL).

Who is sponsoring clinical trial NCT02495155?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02495155 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.